L-Malic Acid → Sunitinib Malate
Reaction equation
[CH3:1][CH2:2][N:3]([CH2:6][CH2:7][NH:8][C:9]([C:11]1[C:15]([CH3:16])=[C:14](/[CH:17]=[C:18]2/[C:19]3[CH:24]=[C:23]([F:25])[CH:22]=[CH:21][C:20]=3[NH:26][C:27]/2=[O:28])[NH:13][C:12]=1[CH3:29])=[O:10])[CH2:4][CH3:5].[C:30]([OH:38])(=[O:37])[C@H:31]([CH2:33][C:34]([OH:36])=[O:35])[OH:32]>O>[CH3:1][CH2:2][N:3]([CH2:6][CH2:7][NH:8][C:9]([C:11]1[C:15]([CH3:16])=[C:14](/[CH:17]=[C:18]2/[C:19]3[CH:24]=[C:23]([F:25])[CH:22]=[CH:21][C:20]=3[NH:26][C:27]/2=[O:28])[NH:13][C:12]=1[CH3:29])=[O:10])[CH2:4][CH3:5].[CH2:33]([C:34]([OH:36])=[O:35])[C@H:31]([OH:32])[C:30]([OH:38])=[O:37]Participants
4
Reactant 2
Product 1
Reagents, catalysts & solvents 1
Procedure
Composition L containing Sunitinib base and L-malic acid (10 mg) was weighted into a vial, then 10 μL of water was added and blended was mixed by shaking the vial. The vial was closed and left at ambient temperature for 32 days until drying, obtaining form I.
Workup
- additionwas added
- additionblended was mixed
- customThe vial was closed
- customuntil drying
- customobtaining form I
Sources & evidence
- ORD record
- ord-7e03ff8fd74b47e39f984bf81526dd67
- Source dataset
- uspto-grants-2015_06
- Patent number
- US09067915B2
Reaction notes
Loading…